Open Access
Figure 4.
Télécharger l'image originale
A. Formule du mirvétuximab soravtansine, anticorps anti-folate R1 conjugué à la DM4 via un espaceur non clivable. B. Formule des dépatuximab mafodotine et bélantuzumab mafodotine, anticorps conjugués à la MMAF via un espaceur non clivable.
Current usage metrics show cumulative count of Article Views (full-text article views including HTML views, PDF and ePub downloads, according to the available data) and Abstracts Views on Vision4Press platform.
Data correspond to usage on the plateform after 2015. The current usage metrics is available 48-96 hours after online publication and is updated daily on week days.
Initial download of the metrics may take a while.